Form 4: Clorox EVP Hilt Reports Routine Stock Transactions

Clorox EVP and Chief Legal Officer Angela C. Hilt reported the vesting of performance units, subsequent tax-related share withholdings, and changes in her beneficial ownership of company common stock.

Summary

• Angela C. Hilt, Executive Vice President and Chief Legal Officer of The Clorox Company, reported stock transactions on October 3, 2025.
• Acquired 8,672 shares of Common Stock at a price of $122.25 per share, resulting from the settlement of a 2022 Performance Unit Grant.
• Disposed of 1,904 shares of Common Stock at $122.25 per share to satisfy tax obligations related to the vesting of restricted stock.
• Disposed of an additional 3,629 shares of Common Stock at $122.25 per share to satisfy tax obligations related to the vesting of performance stock units.
• Following these transactions, direct beneficial ownership of Common Stock was 30,134 shares.
• The reported direct beneficial ownership includes 462 shares acquired through a dividend reinvestment feature of the Company's Stock Incentive Plan.
• Indirectly owns 612.574 shares through the Company's 401(k) plan as of October 3, 2025.

Sentiment

Score: 7

Explanation: The filing reflects the routine vesting of executive compensation, indicating performance targets were met, which is generally positive for the company's operational execution. The subsequent share disposals are solely for tax purposes and not a discretionary sale, thus having a neutral impact on company sentiment.

Positives

• The vesting of 8,672 performance units indicates the achievement of performance targets set in 2022, reflecting positively on the company's operational execution during that period.

Negatives

• A total of 5,533 shares were withheld by the company to cover tax obligations, which reduced the executive's direct beneficial ownership.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of executive compensation and does not provide specific insights into broader industry trends or competitive positioning. It reflects standard practices for equity-based incentive plans within the consumer goods sector.

Stakeholder Impact

• Shareholders: The filing provides transparency into executive compensation practices and the achievement of performance-based incentives, which can be viewed as a positive indicator of past performance.
• Employees: Reflects standard executive compensation structures, which may influence broader compensation strategies within the company.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation events, specifically the vesting of performance units and subsequent tax-related share withholdings. It does not provide new material information regarding the company's operational performance, financial outlook, or strategic direction that would warrant a change in investment recommendation. The transactions are pre-scheduled and expected, reflecting the achievement of past performance targets rather than a discretionary sale or purchase based on new insights.

Keywords

CLX, Clorox, Form 4, Insider Transaction, Executive Compensation, Stock Vesting, Angela Hilt